Figure 5 presents a detailed network analysis revealing close interactions between the CER1, FRAT1, FSTL1, and BMP2 genes and 12 independent genes identified across 10 oncogenic signaling pathways that are significantly associated with prognosis in GBM patients. This evidence concerns the gene CER1 and glioblastoma.